No Data
10-K: FY2024 Annual Report
Express News | Heartsciences Provides Business Update and Reports Fiscal 2024 Financial Results
Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista WavECG Potential to Improve Cardiovascular Pathway Efficiency
HeartSciences Selected to Demonstrate MyoVista WavECG at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
Express News | Heartsciences Regains Compliance With Nasdaq Listing Requirements
No Data